Table 2.
Comorbidity and Cardiovascular Drug Treatment at the Time the ECGs were Recorded, and on Discharge
| Survivors | Nonsurvivors | ||
|---|---|---|---|
| (n = 1275) | (n = 109) | ||
| Comorbidity | % | % | P* |
| • Previous PCI | 12.0 | 3.9 | 0.025 |
| • Previous CABG | 7.3 | 15.5 | 0.003 |
| • Previous AMI | 19.8 | 37.9 | <0.001 |
| • Diabetes | 14.4 | 21.4 | 0.068 |
| • Cancer | 7.7 | 15.5 | 0.006 |
| • Hypertension | 31.7 | 36.9 | 0.27 |
| Drugs on admission | |||
| • Clopidogrel | 84.4 | 67.7 | <0.001 |
| • Aspirin | 92.6 | 84.3 | 0.003 |
| • Beta‐blockers | 62.0 | 75.5 | 0.005 |
| • ACE inhibitors | 21.5 | 34.3 | 0.003 |
| • ATII blocker | 14.9 | 15.7 | 0.83 |
| • Statins | 61.3 | 54.9 | 0.007 |
| Drugs on discharge | |||
| • Clopidogrel | 93.8 | 75.3 | <0.001 |
| • Aspirin | 98.4 | 92.5 | <0.001 |
| • Beta‐blockers | 87.0 | 92.5 | 0.12 |
| • ACE inhibitors | 32.3 | 41.9 | 0.06 |
| • ATII blocker | 13.8 | 12.9 | 0.84 |
| • Statins | 93.4 | 67.7 | <0.001 |
*Wilcoxon two‐sample test